Day 1 – 12th March, 2025

08:30 – 09:00 Welcoming participants

09:00 – 09:10 Introduction Day 1

Marie-Cécile Ploy, EU-JAMRAI 2 coordinator

09:10 – 09:40 Keynotes Day 1

• Representative from the Basque Ministry of Health (10’)
  • Deputy Minister for Health of the Basque Country, Enrique Peiró
  • Director of Health Research, Innovation and Evaluation of the Basque Country, Iñaki Gutiérrez
• European Commission, DG Sante, Velina Pendolovska & Julia Langer (10’)
• WOAH, on behalf of the Quadripartite, Javier Yugueros-Marcos (10’)

09:40 – 11:15 Session 1: Toward a One Health surveillance of AMR in Europe

1- Introduction

2- Animal & environmental surveillance

• Progress update from EU-JAMRAI 2 – Animal surveillance (EARS-Vet)
• Progress update from EU-JAMRAI 2 – Environmental surveillance (EARS-Env)
• Panel discussion: Expectations and added value of EARS-Vet and EARS-Env networks.
  • EFSA, Ernesto Liebana
  • EEA, Caroline Whalley
  • WHO-Europe, Peter Hoejskov

3- Human surveillance & efforts to move forward a One Health surveillance

• Progress update from EU-JAMRAI 2 – Human surveillance
• Progress update from EU-JAMRAI 2 – Moving forward a One Health surveillance
• Panel discussion: How do we direct the JAMRAI 2 surveillance work to have added value to the current surveillance landscape in Europe?
  • European Commission Unit A1, Ariane Vander Stappen
  • European Commission Unit B2, Velina Pendolovska
  • ECDC, Dominique Monnet
  • EFSA, Ernesto Liebana
  • EEA, Caroline Whalley
  • WHO-Europe, Peter Hoejskov

4- Mentimeter – Q&A

5- Wrap up

11:15 – 11:45 Coffee break

11:45 – 12:40 Session 2 (Part 1): Improving implementation in AMS and IPC in a One health perspective

1- Why linking AMS and IPC? – Common goals, shared objectives and targets

2- Panel discussion: The importance of AMS & IPC strategies

• European Commission Unit F5, Iwona Decewicz
• ECDC, Diamantis Plachouras
• EUCIC, Gabriel Birgand
• Drive-AMS, Jeroen Schouten
• Complutense University of Madrid, Bruno Gonzales Zorn

3- Behaviour change as a transversal approach to address AMS and IPC

12:40 – 12:50 Photoshoot

12:50 – 14:00 Lunch Break

14:00 – 15:40 Session 2 (Part 2): Improving implementation in AMS and IPC in a One
health perspective

4- Work from EU-JAMRAI 2 on AMS & IPC

• Efforts in human health
• Efforts in animal health
• Efforts in environmental health
• Q&A

5- Panel discussion: The interlinked impact of our One Health activities (AMS and IPC) – a joint perspective

• WHO, Ana Paula Coutinho
• WOAH, Ana Mateus
• FAO, Francesca Latronico
• EEA, Caroline Whalley

6- Wrap-up & meeting the targets

15:40 – 16:00 Coffee break

16:00 – 17:20 Session 3: Improving access to ensure optimal treatment options for humans and animals in Europe

1- Introduction – Why is EU-JAMRAI-2 focusing on access and what have been done?

2- Focus on veterinary products: the case of access to benzylpenicillin for veterinary use

• Why is sustainable access to benzylpenicillin for veterinary use an issue?
• Panel discussion: The case of access to benzylpenicillin for veterinary use
  • Tita-Maria Muhonen, Finland
  • Cristina Muñoz Madero, Spain
  • Pascal Beyens, Access Vet Med
  • Ana Maria Azaceta Avila, EMA

3- Focus on human products: improving the availability of “access” antibiotics for human use

• Which WHO “access” antibiotics for human use are EU-JAMRAI-2 focusing on?
• Panel discussion: Improving the availability of “access” antibiotics – the case of pediatric penicillins
  • Emma Keuleyan, Bulgaria
  • Michael Borg, Malta
  • Alban Dhanani, France
  • Emilija Matelytė, EMA
  • Boumediene Soufi, Medicines for Europe

4- Wrap up: Looking ahead to next year and general questions

17:20 – 17:30 Conclusion Day 1

Benjamin Davido, French Ministry of Health

17:45 – 19:00 Visit of the Guggenheim Museum

19:00 – 20:30 Free time

20:30 – 22:00 Social event – Cocktail – Guggenheim Museum Restaurant

Day 2 – 13th March, 2025

8:30 – 09:00 Welcoming participants

09:00 – 09:10 Introduction Day 2

Marie-Cécile Ploy, EU-JAMRAI 2 coordinator

09:10 – 09:30 Keynotes Day 2

• OECD, Michele Cecchini (10’)
• European Patients’ Forum, Elena Moya (10’)

09:30 – 10:50 Session 4: Raising global awareness on AMR in Europe

1- Ice breaker

2- Efforts to make EU-JAMRAI 2 visible

• EU-JAMRAI 2 communication and visibility results

3- Renewing AMR Communication

• Video & presentation
• Panel discussion: Renewing AMR Communication
  • WOAH, Javier Yugueros-Marcos
  • UNEP, Pablo Sagredo
  • ECDC, Sarah Earnshaw Blomquist
  • The AMR Narrative, Vanessa Carter

4- Raising awareness on AMR with a GLOCAL approach

• Video & presentation
• Panel discussion: Raising awareness on AMR with a GLOCAL approach
  • European Commission, Unit A3, Edward Demicoli
  • EFSA, Giovanni Mancarella
  • EU-JAMRAI 2 COM Network Members – Croatia, Selma Bošnjak
  • EU-JAMRAI 2 COM Network Members – Iceland, Rebekka Aldís Kristinsdóttir Valberg

5- Wrap up – Goals for next year

10:50 – 11:20 Coffee Break

11:20 – 12:40 Session 5: Building a bridge from actions to One Health policies with a sustainable impact

1- Introduction

2- Why are we building this bridge?

• Presentation

3- How can we build this bridge… from actions to one health policies?

• Presentation
• Panel discussion with Liaison Officers:
  • Thomas Janssen (Belgium)
  • Anna Margret Halldorsdottir (Iceland)
  • Maja Subelj (Slovenia)
  • Marta Gutiérrez (Spain)

4- What do we do and offer to build this bridge?

• EU-JAMRAI 2 presentation
• Keynote from European Commission, Unit A1, Ariane Vander Stappen
• Panel discussion:
  • ECDC, Dominique Monnet
  • EFSA, Ernesto Liebana
  • WHO-Europe, Danilo Lo Fo Wong

5 – Q&A + Wrap up

12:40 – 12:50 Conclusion Day 2

Didier Samuel, Chairman and Chief Executive Officer of Inserm

12:50 – 12:55 Mentimeter – Evaluating the EU-JAMRAI 2 annual meeting

12:55 – 14:00 Cocktail for participants